nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Quinidine—ABCC2—esophageal cancer	0.0109	0.291	CrCbGaD
Quinidine barbiturate—Necrosis—Cisplatin—esophageal cancer	0.0072	0.00959	CcSEcCtD
Quinidine barbiturate—Liver injury—Cisplatin—esophageal cancer	0.00671	0.00894	CcSEcCtD
Quinidine barbiturate—Extravasation—Cisplatin—esophageal cancer	0.00648	0.00862	CcSEcCtD
Quinidine barbiturate—Aphasia—Capecitabine—esophageal cancer	0.00642	0.00855	CcSEcCtD
Quinidine barbiturate—Phenobarbital—CYP1B1—esophageal cancer	0.00635	0.169	CrCbGaD
Quinidine barbiturate—Torsade de pointes—Capecitabine—esophageal cancer	0.00594	0.00791	CcSEcCtD
Quinidine barbiturate—Hearing impaired—Cisplatin—esophageal cancer	0.00593	0.00791	CcSEcCtD
Quinidine barbiturate—Pain—Carboplatin—esophageal cancer	0.00588	0.00783	CcSEcCtD
Quinidine barbiturate—Azotaemia—Methotrexate—esophageal cancer	0.00582	0.00775	CcSEcCtD
Quinidine barbiturate—Blister—Capecitabine—esophageal cancer	0.00578	0.0077	CcSEcCtD
Quinidine barbiturate—Hepatocellular injury—Cisplatin—esophageal cancer	0.00565	0.00753	CcSEcCtD
Quinidine barbiturate—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00544	0.00724	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Carboplatin—esophageal cancer	0.00543	0.00724	CcSEcCtD
Quinidine barbiturate—Hepatotoxicity—Capecitabine—esophageal cancer	0.00539	0.00718	CcSEcCtD
Quinidine barbiturate—Coagulopathy—Capecitabine—esophageal cancer	0.00535	0.00712	CcSEcCtD
Quinidine barbiturate—Petechiae—Capecitabine—esophageal cancer	0.00506	0.00674	CcSEcCtD
Quinidine barbiturate—Phenobarbital—ABCC2—esophageal cancer	0.00495	0.132	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP2A6—esophageal cancer	0.0049	0.13	CrCbGaD
Quinidine barbiturate—Hypoxia—Methotrexate—esophageal cancer	0.00488	0.0065	CcSEcCtD
Quinidine barbiturate—Aphasia—Methotrexate—esophageal cancer	0.00478	0.00637	CcSEcCtD
Quinidine barbiturate—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00461	0.00614	CcSEcCtD
Quinidine barbiturate—Deafness—Cisplatin—esophageal cancer	0.00458	0.00611	CcSEcCtD
Quinidine barbiturate—Quinine—ABCB1—esophageal cancer	0.00458	0.122	CrCbGaD
Quinidine barbiturate—Hypocalcaemia—Capecitabine—esophageal cancer	0.00455	0.00606	CcSEcCtD
Quinidine barbiturate—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00454	0.00605	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Cisplatin—esophageal cancer	0.00444	0.00592	CcSEcCtD
Quinidine barbiturate—Hearing impaired—Capecitabine—esophageal cancer	0.00437	0.00583	CcSEcCtD
Quinidine barbiturate—Injection site reaction—Capecitabine—esophageal cancer	0.00414	0.00551	CcSEcCtD
Quinidine barbiturate—Quinidine—ABCB1—esophageal cancer	0.00402	0.107	CrCbGaD
Quinidine barbiturate—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00402	0.00536	CcSEcCtD
Quinidine barbiturate—Hepatotoxicity—Methotrexate—esophageal cancer	0.00401	0.00535	CcSEcCtD
Quinidine barbiturate—Necrosis—Methotrexate—esophageal cancer	0.00395	0.00526	CcSEcCtD
Quinidine barbiturate—Irritability—Cisplatin—esophageal cancer	0.00391	0.00521	CcSEcCtD
Quinidine barbiturate—Oesophagitis—Capecitabine—esophageal cancer	0.00381	0.00507	CcSEcCtD
Quinidine barbiturate—Petechiae—Methotrexate—esophageal cancer	0.00377	0.00502	CcSEcCtD
Quinidine barbiturate—Ecchymosis—Capecitabine—esophageal cancer	0.00377	0.00502	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00375	0.00499	CcSEcCtD
Quinidine barbiturate—Breast disorder—Cisplatin—esophageal cancer	0.00371	0.00494	CcSEcCtD
Quinidine barbiturate—Apnoea—Methotrexate—esophageal cancer	0.00366	0.00487	CcSEcCtD
Quinidine barbiturate—Mental disability—Capecitabine—esophageal cancer	0.00361	0.00481	CcSEcCtD
Quinidine barbiturate—Extravasation—Methotrexate—esophageal cancer	0.00355	0.00473	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Capecitabine—esophageal cancer	0.00344	0.00459	CcSEcCtD
Quinidine barbiturate—Bone disorder—Methotrexate—esophageal cancer	0.00343	0.00457	CcSEcCtD
Quinidine barbiturate—Deafness—Capecitabine—esophageal cancer	0.00338	0.0045	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Cisplatin—esophageal cancer	0.00337	0.00448	CcSEcCtD
Quinidine barbiturate—Oliguria—Methotrexate—esophageal cancer	0.00336	0.00448	CcSEcCtD
Quinidine barbiturate—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00335	0.00446	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Capecitabine—esophageal cancer	0.00327	0.00436	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.0032	0.00427	CcSEcCtD
Quinidine barbiturate—Renal impairment—Capecitabine—esophageal cancer	0.00318	0.00423	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Capecitabine—esophageal cancer	0.00316	0.00421	CcSEcCtD
Quinidine barbiturate—Respiratory failure—Methotrexate—esophageal cancer	0.00316	0.0042	CcSEcCtD
Quinidine barbiturate—Purpura—Capecitabine—esophageal cancer	0.00314	0.00418	CcSEcCtD
Quinidine barbiturate—Renal failure—Cisplatin—esophageal cancer	0.00311	0.00414	CcSEcCtD
Quinidine barbiturate—Lethargy—Capecitabine—esophageal cancer	0.00308	0.00411	CcSEcCtD
Quinidine barbiturate—Diplopia—Capecitabine—esophageal cancer	0.00302	0.00403	CcSEcCtD
Quinidine barbiturate—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00299	0.00399	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Methotrexate—esophageal cancer	0.00291	0.00388	CcSEcCtD
Quinidine barbiturate—Bradycardia—Cisplatin—esophageal cancer	0.00289	0.00385	CcSEcCtD
Quinidine barbiturate—Irritability—Capecitabine—esophageal cancer	0.00289	0.00384	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Capecitabine—esophageal cancer	0.00287	0.00383	CcSEcCtD
Quinidine barbiturate—Mood swings—Capecitabine—esophageal cancer	0.00286	0.00381	CcSEcCtD
Quinidine barbiturate—Ataxia—Capecitabine—esophageal cancer	0.00284	0.00379	CcSEcCtD
Quinidine barbiturate—Coma—Methotrexate—esophageal cancer	0.00283	0.00377	CcSEcCtD
Quinidine barbiturate—Ecchymosis—Methotrexate—esophageal cancer	0.0028	0.00373	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Cisplatin—esophageal cancer	0.0028	0.00373	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Capecitabine—esophageal cancer	0.00279	0.00372	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Cisplatin—esophageal cancer	0.00278	0.0037	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00276	0.00368	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Capecitabine—esophageal cancer	0.00276	0.00368	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Methotrexate—esophageal cancer	0.00276	0.00368	CcSEcCtD
Quinidine barbiturate—Visual impairment—Cisplatin—esophageal cancer	0.00273	0.00364	CcSEcCtD
Quinidine barbiturate—Breast disorder—Capecitabine—esophageal cancer	0.00273	0.00364	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00272	0.00363	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Capecitabine—esophageal cancer	0.00267	0.00355	CcSEcCtD
Quinidine barbiturate—Eye disorder—Cisplatin—esophageal cancer	0.00265	0.00353	CcSEcCtD
Quinidine barbiturate—Tinnitus—Cisplatin—esophageal cancer	0.00265	0.00352	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Cisplatin—esophageal cancer	0.00263	0.00351	CcSEcCtD
Quinidine barbiturate—Flushing—Cisplatin—esophageal cancer	0.00263	0.00351	CcSEcCtD
Quinidine barbiturate—Asthma—Capecitabine—esophageal cancer	0.00261	0.00348	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Capecitabine—esophageal cancer	0.00257	0.00342	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Methotrexate—esophageal cancer	0.00256	0.00341	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Cisplatin—esophageal cancer	0.00256	0.00341	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Cisplatin—esophageal cancer	0.00256	0.00341	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Capecitabine—esophageal cancer	0.00255	0.00339	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Capecitabine—esophageal cancer	0.00248	0.0033	CcSEcCtD
Quinidine barbiturate—Malnutrition—Cisplatin—esophageal cancer	0.00247	0.00329	CcSEcCtD
Quinidine barbiturate—Erythema—Cisplatin—esophageal cancer	0.00247	0.00329	CcSEcCtD
Quinidine barbiturate—Neutropenia—Capecitabine—esophageal cancer	0.00244	0.00325	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Methotrexate—esophageal cancer	0.00244	0.00325	CcSEcCtD
Quinidine barbiturate—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00238	0.00318	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00238	0.00318	CcSEcCtD
Quinidine barbiturate—Visual disturbance—Methotrexate—esophageal cancer	0.00237	0.00316	CcSEcCtD
Quinidine barbiturate—Vision blurred—Cisplatin—esophageal cancer	0.00233	0.0031	CcSEcCtD
Quinidine barbiturate—Tremor—Cisplatin—esophageal cancer	0.00231	0.00308	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00231	0.00308	CcSEcCtD
Quinidine barbiturate—Lethargy—Methotrexate—esophageal cancer	0.0023	0.00306	CcSEcCtD
Quinidine barbiturate—Renal failure—Capecitabine—esophageal cancer	0.00229	0.00305	CcSEcCtD
Quinidine barbiturate—Jaundice—Capecitabine—esophageal cancer	0.00227	0.00302	CcSEcCtD
Quinidine barbiturate—Leukopenia—Cisplatin—esophageal cancer	0.00221	0.00294	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Capecitabine—esophageal cancer	0.00217	0.0029	CcSEcCtD
Quinidine barbiturate—Irritability—Methotrexate—esophageal cancer	0.00215	0.00286	CcSEcCtD
Quinidine barbiturate—Convulsion—Cisplatin—esophageal cancer	0.00214	0.00285	CcSEcCtD
Quinidine barbiturate—Mood swings—Methotrexate—esophageal cancer	0.00213	0.00284	CcSEcCtD
Quinidine barbiturate—Bradycardia—Capecitabine—esophageal cancer	0.00213	0.00284	CcSEcCtD
Quinidine barbiturate—Ataxia—Methotrexate—esophageal cancer	0.00212	0.00282	CcSEcCtD
Quinidine barbiturate—Myalgia—Cisplatin—esophageal cancer	0.0021	0.0028	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Capecitabine—esophageal cancer	0.0021	0.0028	CcSEcCtD
Quinidine barbiturate—Anxiety—Cisplatin—esophageal cancer	0.0021	0.00279	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Capecitabine—esophageal cancer	0.00209	0.00279	CcSEcCtD
Quinidine barbiturate—Hepatitis—Capecitabine—esophageal cancer	0.00209	0.00279	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00209	0.00278	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Methotrexate—esophageal cancer	0.00208	0.00277	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Capecitabine—esophageal cancer	0.00207	0.00275	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Capecitabine—esophageal cancer	0.00205	0.00273	CcSEcCtD
Quinidine barbiturate—Breast disorder—Methotrexate—esophageal cancer	0.00203	0.00271	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00203	0.0027	CcSEcCtD
Quinidine barbiturate—Oedema—Cisplatin—esophageal cancer	0.00202	0.00268	CcSEcCtD
Quinidine barbiturate—Visual impairment—Capecitabine—esophageal cancer	0.00202	0.00268	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Capecitabine—esophageal cancer	0.00198	0.00263	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Cisplatin—esophageal cancer	0.00198	0.00263	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Cisplatin—esophageal cancer	0.00197	0.00263	CcSEcCtD
Quinidine barbiturate—Tachycardia—Cisplatin—esophageal cancer	0.00197	0.00262	CcSEcCtD
Quinidine barbiturate—Skin disorder—Cisplatin—esophageal cancer	0.00196	0.00261	CcSEcCtD
Quinidine barbiturate—Eye disorder—Capecitabine—esophageal cancer	0.00195	0.0026	CcSEcCtD
Quinidine barbiturate—Tinnitus—Capecitabine—esophageal cancer	0.00195	0.0026	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Cisplatin—esophageal cancer	0.00195	0.0026	CcSEcCtD
Quinidine barbiturate—Asthma—Methotrexate—esophageal cancer	0.00194	0.00259	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Capecitabine—esophageal cancer	0.00194	0.00259	CcSEcCtD
Quinidine barbiturate—Flushing—Capecitabine—esophageal cancer	0.00194	0.00259	CcSEcCtD
Quinidine barbiturate—Anorexia—Cisplatin—esophageal cancer	0.00192	0.00256	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Capecitabine—esophageal cancer	0.00189	0.00252	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Capecitabine—esophageal cancer	0.00188	0.00251	CcSEcCtD
Quinidine barbiturate—Hypotension—Cisplatin—esophageal cancer	0.00188	0.00251	CcSEcCtD
Quinidine barbiturate—Chills—Capecitabine—esophageal cancer	0.00188	0.0025	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Methotrexate—esophageal cancer	0.00185	0.00246	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00184	0.00245	CcSEcCtD
Quinidine barbiturate—Mental disorder—Capecitabine—esophageal cancer	0.00183	0.00244	CcSEcCtD
Quinidine barbiturate—Phenobarbital—ABCB1—esophageal cancer	0.00182	0.0485	CrCbGaD
Quinidine barbiturate—Erythema—Capecitabine—esophageal cancer	0.00182	0.00242	CcSEcCtD
Quinidine barbiturate—Malnutrition—Capecitabine—esophageal cancer	0.00182	0.00242	CcSEcCtD
Quinidine barbiturate—Neutropenia—Methotrexate—esophageal cancer	0.00182	0.00242	CcSEcCtD
Quinidine barbiturate—GABRA2—Ion channel transport—ATP1B2—esophageal cancer	0.00182	0.00858	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Cisplatin—esophageal cancer	0.0018	0.00239	CcSEcCtD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—esophageal cancer	0.00179	0.00847	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CFL1—esophageal cancer	0.00179	0.00847	CbGpPWpGaD
Quinidine barbiturate—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00178	0.00236	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Cisplatin—esophageal cancer	0.00175	0.00233	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00174	0.00232	CcSEcCtD
Quinidine barbiturate—Drowsiness—Methotrexate—esophageal cancer	0.00173	0.00231	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00173	0.00817	CbGpPWpGaD
Quinidine barbiturate—Pain—Cisplatin—esophageal cancer	0.00172	0.0023	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00172	0.00229	CcSEcCtD
Quinidine barbiturate—Vision blurred—Capecitabine—esophageal cancer	0.00172	0.00229	CcSEcCtD
Quinidine barbiturate—Tremor—Capecitabine—esophageal cancer	0.00171	0.00227	CcSEcCtD
Quinidine barbiturate—Renal failure—Methotrexate—esophageal cancer	0.0017	0.00227	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.0017	0.00802	CbGpPWpGaD
Quinidine barbiturate—Sweating—Methotrexate—esophageal cancer	0.00166	0.00221	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Cisplatin—esophageal cancer	0.00166	0.00221	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00166	0.00785	CbGpPWpGaD
Quinidine barbiturate—Vertigo—Capecitabine—esophageal cancer	0.00164	0.00218	CcSEcCtD
Quinidine barbiturate—Syncope—Capecitabine—esophageal cancer	0.00163	0.00217	CcSEcCtD
Quinidine barbiturate—Leukopenia—Capecitabine—esophageal cancer	0.00163	0.00217	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Methotrexate—esophageal cancer	0.00162	0.00216	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00161	0.0076	CbGpPWpGaD
Quinidine barbiturate—Palpitations—Capecitabine—esophageal cancer	0.00161	0.00214	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Capecitabine—esophageal cancer	0.0016	0.00213	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Cisplatin—esophageal cancer	0.00159	0.00212	CcSEcCtD
Quinidine barbiturate—CYP2D6—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00159	0.00751	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—ATP4A—esophageal cancer	0.00158	0.00744	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—KDR—esophageal cancer	0.00157	0.00741	CbGpPWpGaD
Quinidine barbiturate—Haemoglobin—Methotrexate—esophageal cancer	0.00156	0.00208	CcSEcCtD
Quinidine barbiturate—Hepatitis—Methotrexate—esophageal cancer	0.00156	0.00207	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Methotrexate—esophageal cancer	0.00156	0.00207	CcSEcCtD
Quinidine barbiturate—Arthralgia—Capecitabine—esophageal cancer	0.00155	0.00206	CcSEcCtD
Quinidine barbiturate—Chest pain—Capecitabine—esophageal cancer	0.00155	0.00206	CcSEcCtD
Quinidine barbiturate—Myalgia—Capecitabine—esophageal cancer	0.00155	0.00206	CcSEcCtD
Quinidine barbiturate—GABRA1—Ion channel transport—ATP1B2—esophageal cancer	0.00155	0.00732	CbGpPWpGaD
Quinidine barbiturate—Anxiety—Capecitabine—esophageal cancer	0.00154	0.00206	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00154	0.00205	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Methotrexate—esophageal cancer	0.00154	0.00205	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00153	0.00724	CbGpPWpGaD
Quinidine barbiturate—Urethral disorder—Methotrexate—esophageal cancer	0.00153	0.00203	CcSEcCtD
Quinidine barbiturate—Visual impairment—Methotrexate—esophageal cancer	0.0015	0.002	CcSEcCtD
Quinidine barbiturate—Confusional state—Capecitabine—esophageal cancer	0.0015	0.002	CcSEcCtD
Quinidine barbiturate—Oedema—Capecitabine—esophageal cancer	0.00149	0.00198	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00149	0.00702	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Cisplatin—esophageal cancer	0.00148	0.00198	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00148	0.00699	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—esophageal cancer	0.00148	0.00698	CbGpPWpGaD
Quinidine barbiturate—Erythema multiforme—Methotrexate—esophageal cancer	0.00147	0.00196	CcSEcCtD
Quinidine barbiturate—Shock—Capecitabine—esophageal cancer	0.00146	0.00195	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Capecitabine—esophageal cancer	0.00146	0.00194	CcSEcCtD
Quinidine barbiturate—Eye disorder—Methotrexate—esophageal cancer	0.00145	0.00194	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Capecitabine—esophageal cancer	0.00145	0.00194	CcSEcCtD
Quinidine barbiturate—Tinnitus—Methotrexate—esophageal cancer	0.00145	0.00193	CcSEcCtD
Quinidine barbiturate—Tachycardia—Capecitabine—esophageal cancer	0.00145	0.00193	CcSEcCtD
Quinidine barbiturate—Asthenia—Cisplatin—esophageal cancer	0.00145	0.00193	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Methotrexate—esophageal cancer	0.00144	0.00192	CcSEcCtD
Quinidine barbiturate—Skin disorder—Capecitabine—esophageal cancer	0.00144	0.00192	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Capecitabine—esophageal cancer	0.00144	0.00191	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00143	0.00678	CbGpPWpGaD
Quinidine barbiturate—Anorexia—Capecitabine—esophageal cancer	0.00142	0.00189	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Methotrexate—esophageal cancer	0.00141	0.00187	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Methotrexate—esophageal cancer	0.0014	0.00187	CcSEcCtD
Quinidine barbiturate—Chills—Methotrexate—esophageal cancer	0.0014	0.00186	CcSEcCtD
Quinidine barbiturate—Hypotension—Capecitabine—esophageal cancer	0.00139	0.00185	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Cisplatin—esophageal cancer	0.00138	0.00184	CcSEcCtD
Quinidine barbiturate—Mental disorder—Methotrexate—esophageal cancer	0.00136	0.00182	CcSEcCtD
Quinidine barbiturate—Erythema—Methotrexate—esophageal cancer	0.00136	0.00181	CcSEcCtD
Quinidine barbiturate—Malnutrition—Methotrexate—esophageal cancer	0.00136	0.00181	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00135	0.0018	CcSEcCtD
Quinidine barbiturate—GABRA1—Ion channel transport—ATP4A—esophageal cancer	0.00134	0.00635	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.00133	0.00628	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Capecitabine—esophageal cancer	0.00132	0.00176	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.0013	0.00614	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ATP1B2—esophageal cancer	0.0013	0.00613	CbGpPWpGaD
Quinidine barbiturate—Decreased appetite—Capecitabine—esophageal cancer	0.00129	0.00172	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00128	0.00171	CcSEcCtD
Quinidine barbiturate—Vomiting—Cisplatin—esophageal cancer	0.00128	0.00171	CcSEcCtD
Quinidine barbiturate—Vision blurred—Methotrexate—esophageal cancer	0.00128	0.0017	CcSEcCtD
Quinidine barbiturate—Rash—Cisplatin—esophageal cancer	0.00127	0.00169	CcSEcCtD
Quinidine barbiturate—Pain—Capecitabine—esophageal cancer	0.00127	0.00169	CcSEcCtD
Quinidine barbiturate—Constipation—Capecitabine—esophageal cancer	0.00127	0.00169	CcSEcCtD
Quinidine barbiturate—Dermatitis—Cisplatin—esophageal cancer	0.00127	0.00169	CcSEcCtD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—CYP1B1—esophageal cancer	0.00123	0.0058	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Capecitabine—esophageal cancer	0.00122	0.00163	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00122	0.00575	CbGpPWpGaD
Quinidine barbiturate—Vertigo—Methotrexate—esophageal cancer	0.00122	0.00162	CcSEcCtD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00122	0.00575	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00121	0.00162	CcSEcCtD
Quinidine barbiturate—Leukopenia—Methotrexate—esophageal cancer	0.00121	0.00162	CcSEcCtD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—FKBP1A—esophageal cancer	0.0012	0.00567	CbGpPWpGaD
Quinidine barbiturate—Nausea—Cisplatin—esophageal cancer	0.0012	0.00159	CcSEcCtD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00119	0.00564	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00119	0.00561	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Capecitabine—esophageal cancer	0.00118	0.00157	CcSEcCtD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00118	0.00557	CbGpPWpGaD
Quinidine barbiturate—Abdominal pain—Capecitabine—esophageal cancer	0.00117	0.00156	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Capecitabine—esophageal cancer	0.00117	0.00156	CcSEcCtD
Quinidine barbiturate—Convulsion—Methotrexate—esophageal cancer	0.00117	0.00156	CcSEcCtD
Quinidine barbiturate—Chest pain—Methotrexate—esophageal cancer	0.00115	0.00154	CcSEcCtD
Quinidine barbiturate—Arthralgia—Methotrexate—esophageal cancer	0.00115	0.00154	CcSEcCtD
Quinidine barbiturate—Myalgia—Methotrexate—esophageal cancer	0.00115	0.00154	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00115	0.00544	CbGpPWpGaD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00115	0.00153	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00112	0.00527	CbGpPWpGaD
Quinidine barbiturate—Confusional state—Methotrexate—esophageal cancer	0.00112	0.00149	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Capecitabine—esophageal cancer	0.00109	0.00146	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00109	0.00517	CbGpPWpGaD
Quinidine barbiturate—Nervous system disorder—Methotrexate—esophageal cancer	0.00108	0.00144	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Methotrexate—esophageal cancer	0.00108	0.00144	CcSEcCtD
Quinidine barbiturate—Skin disorder—Methotrexate—esophageal cancer	0.00107	0.00143	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Methotrexate—esophageal cancer	0.00107	0.00142	CcSEcCtD
Quinidine barbiturate—Asthenia—Capecitabine—esophageal cancer	0.00107	0.00142	CcSEcCtD
Quinidine barbiturate—Anorexia—Methotrexate—esophageal cancer	0.00105	0.0014	CcSEcCtD
Quinidine barbiturate—SCN5A—Axon guidance—PFN1—esophageal cancer	0.00105	0.00498	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Capecitabine—esophageal cancer	0.00105	0.0014	CcSEcCtD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00104	0.00492	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG7—esophageal cancer	0.00104	0.0049	CbGpPWpGaD
Quinidine barbiturate—Hypotension—Methotrexate—esophageal cancer	0.00103	0.00138	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Capecitabine—esophageal cancer	0.00102	0.00135	CcSEcCtD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PFN1—esophageal cancer	0.00101	0.00478	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00101	0.00477	CbGpPWpGaD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—PIK3CA—esophageal cancer	0.00101	0.00477	CbGpPWpGaD
Quinidine barbiturate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00101	0.00134	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—GNG7—esophageal cancer	0.000996	0.0047	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Methotrexate—esophageal cancer	0.000986	0.00131	CcSEcCtD
Quinidine barbiturate—Somnolence—Methotrexate—esophageal cancer	0.000983	0.00131	CcSEcCtD
Quinidine barbiturate—Dizziness—Capecitabine—esophageal cancer	0.000983	0.00131	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.000975	0.00461	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000969	0.00458	CbGpPWpGaD
Quinidine barbiturate—Decreased appetite—Methotrexate—esophageal cancer	0.000961	0.00128	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000955	0.00127	CcSEcCtD
Quinidine barbiturate—Pain—Methotrexate—esophageal cancer	0.000946	0.00126	CcSEcCtD
Quinidine barbiturate—Vomiting—Capecitabine—esophageal cancer	0.000945	0.00126	CcSEcCtD
Quinidine barbiturate—Rash—Capecitabine—esophageal cancer	0.000937	0.00125	CcSEcCtD
Quinidine barbiturate—Dermatitis—Capecitabine—esophageal cancer	0.000936	0.00125	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—ALDH2—esophageal cancer	0.000933	0.00441	CbGpPWpGaD
Quinidine barbiturate—Headache—Capecitabine—esophageal cancer	0.000931	0.00124	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.000915	0.00432	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Methotrexate—esophageal cancer	0.000911	0.00121	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000904	0.0012	CcSEcCtD
Quinidine barbiturate—Nausea—Capecitabine—esophageal cancer	0.000883	0.00118	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—GNG7—esophageal cancer	0.00088	0.00416	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Methotrexate—esophageal cancer	0.000879	0.00117	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Methotrexate—esophageal cancer	0.000874	0.00116	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Methotrexate—esophageal cancer	0.000874	0.00116	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000858	0.00405	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.000857	0.00405	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CFL1—esophageal cancer	0.000854	0.00403	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000851	0.00402	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00084	0.00397	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—ALDH2—esophageal cancer	0.000824	0.00389	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—CFL1—esophageal cancer	0.00082	0.00387	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Methotrexate—esophageal cancer	0.000815	0.00109	CcSEcCtD
Quinidine barbiturate—Asthenia—Methotrexate—esophageal cancer	0.000794	0.00106	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00079	0.00373	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Methotrexate—esophageal cancer	0.000783	0.00104	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00078	0.00369	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—GNG7—esophageal cancer	0.000773	0.00365	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—SFN—esophageal cancer	0.000767	0.00362	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.000763	0.00361	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000758	0.00358	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Methotrexate—esophageal cancer	0.000757	0.00101	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—PFN1—esophageal cancer	0.000752	0.00355	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000734	0.00347	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Methotrexate—esophageal cancer	0.000731	0.000974	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.000731	0.00345	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ACTB—esophageal cancer	0.000726	0.00343	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Methotrexate—esophageal cancer	0.000703	0.000937	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—GNG7—esophageal cancer	0.000701	0.00331	CbGpPWpGaD
Quinidine barbiturate—Rash—Methotrexate—esophageal cancer	0.000697	0.000929	CcSEcCtD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—ACTB—esophageal cancer	0.000697	0.00329	CbGpPWpGaD
Quinidine barbiturate—Dermatitis—Methotrexate—esophageal cancer	0.000697	0.000928	CcSEcCtD
Quinidine barbiturate—Headache—Methotrexate—esophageal cancer	0.000693	0.000923	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000691	0.00327	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00069	0.00326	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000686	0.00324	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000677	0.0032	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000672	0.00318	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00067	0.00317	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—ALDH2—esophageal cancer	0.000657	0.0031	CbGpPWpGaD
Quinidine barbiturate—Nausea—Methotrexate—esophageal cancer	0.000657	0.000875	CcSEcCtD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000654	0.00309	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000645	0.00305	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000637	0.00301	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000632	0.00299	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.000631	0.00298	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—CALR—esophageal cancer	0.000611	0.00288	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CFL1—esophageal cancer	0.000609	0.00288	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Orphan transporters—CREBBP—esophageal cancer	0.000604	0.00285	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000599	0.00283	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GNG7—esophageal cancer	0.000598	0.00282	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000594	0.0028	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SOX2—esophageal cancer	0.000589	0.00278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00058	0.00274	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000573	0.00271	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000572	0.0027	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000565	0.00267	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—ALDH2—esophageal cancer	0.00056	0.00265	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000556	0.00263	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000553	0.00261	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000548	0.00259	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000548	0.00259	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000547	0.00259	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000539	0.00255	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—GNG7—esophageal cancer	0.000537	0.00254	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000523	0.00247	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ACTB—esophageal cancer	0.000518	0.00245	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000515	0.00243	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000515	0.00243	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000511	0.00241	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNA1—esophageal cancer	0.000509	0.00241	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000507	0.0024	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000488	0.0023	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ABL1—esophageal cancer	0.000486	0.0023	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—EGFR—esophageal cancer	0.000483	0.00228	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000478	0.00226	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL2—esophageal cancer	0.000473	0.00223	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.000472	0.00223	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000467	0.00221	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000467	0.00221	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000455	0.00215	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—ANXA1—esophageal cancer	0.00044	0.00208	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—SST—esophageal cancer	0.000428	0.00202	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000415	0.00196	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.00039	0.00184	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000385	0.00182	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000377	0.00178	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.000376	0.00178	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000373	0.00176	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000372	0.00176	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000371	0.00175	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KDR—esophageal cancer	0.000368	0.00174	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000367	0.00173	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—esophageal cancer	0.000361	0.0017	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000357	0.00168	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000354	0.00167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.00035	0.00165	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000348	0.00164	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ABL1—esophageal cancer	0.000347	0.00164	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00034	0.00161	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—SMAD4—esophageal cancer	0.000336	0.00159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.000331	0.00157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.000328	0.00155	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GNG7—esophageal cancer	0.000325	0.00154	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000321	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADCYAP1—esophageal cancer	0.000298	0.00141	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000296	0.0014	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000291	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000291	0.00138	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL2—esophageal cancer	0.000286	0.00135	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000278	0.00131	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000274	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GDI2—esophageal cancer	0.000273	0.00129	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ANXA1—esophageal cancer	0.000266	0.00126	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ERBB2—esophageal cancer	0.000264	0.00124	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KDR—esophageal cancer	0.000263	0.00124	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—SST—esophageal cancer	0.000259	0.00122	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—esophageal cancer	0.000257	0.00122	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000253	0.0012	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—GHRL—esophageal cancer	0.000252	0.00119	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—NOTCH1—esophageal cancer	0.000248	0.00117	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00023	0.00109	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CREBBP—esophageal cancer	0.000225	0.00106	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.00022	0.00104	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKAP13—esophageal cancer	0.000211	0.000998	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000198	0.000937	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KMT2D—esophageal cancer	0.000197	0.000932	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000196	0.000925	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000193	0.000912	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKAP13—esophageal cancer	0.000192	0.000906	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ERBB2—esophageal cancer	0.000188	0.000888	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000188	0.000888	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GNG7—esophageal cancer	0.000184	0.000868	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—esophageal cancer	0.000183	0.000863	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADCYAP1—esophageal cancer	0.000176	0.000831	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PDE4D—esophageal cancer	0.000175	0.000829	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000175	0.000829	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GNG7—esophageal cancer	0.000167	0.000788	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000162	0.000765	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WWOX—esophageal cancer	0.000161	0.00076	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—esophageal cancer	0.000153	0.000723	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	0.000153	0.000722	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000152	0.000719	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	0.00015	0.000711	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WIF1—esophageal cancer	0.000149	0.000706	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000149	0.000705	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000149	0.000705	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000147	0.000696	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.000147	0.000694	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000146	0.000691	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000143	0.000674	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000138	0.000652	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000137	0.000646	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000133	0.000628	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—esophageal cancer	0.00013	0.000616	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.00013	0.000612	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.000129	0.00061	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000127	0.0006	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CA1—esophageal cancer	0.000127	0.0006	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000126	0.000594	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CA2—esophageal cancer	0.000116	0.000548	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.000116	0.000548	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000113	0.000535	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000108	0.00051	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000108	0.00051	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000105	0.000494	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000104	0.000489	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GNG7—esophageal cancer	9.85e-05	0.000466	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ADH1B—esophageal cancer	9.46e-05	0.000447	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—XIAP—esophageal cancer	9.23e-05	0.000436	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TYMP—esophageal cancer	9.04e-05	0.000427	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP26A1—esophageal cancer	8.8e-05	0.000416	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	8.73e-05	0.000413	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	8.68e-05	0.00041	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALOX15—esophageal cancer	8.57e-05	0.000405	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPI1—esophageal cancer	8.18e-05	0.000386	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.18e-05	0.000386	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSME2—esophageal cancer	8.11e-05	0.000383	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSME1—esophageal cancer	8.11e-05	0.000383	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	8.07e-05	0.000381	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SST—esophageal cancer	7.85e-05	0.000371	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALDOB—esophageal cancer	7.84e-05	0.00037	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GHRL—esophageal cancer	7.65e-05	0.000361	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	7.65e-05	0.000361	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GAPDH—esophageal cancer	7.55e-05	0.000357	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	7.53e-05	0.000356	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CRABP1—esophageal cancer	7.48e-05	0.000353	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GNG7—esophageal cancer	7.12e-05	0.000336	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	6.86e-05	0.000324	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALDH2—esophageal cancer	6.67e-05	0.000315	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.34e-05	0.0003	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.27e-05	0.000296	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	6.09e-05	0.000288	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ENO1—esophageal cancer	5.94e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS1—esophageal cancer	5.94e-05	0.000281	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PSME2—esophageal cancer	5.86e-05	0.000277	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PSME1—esophageal cancer	5.86e-05	0.000277	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	5.76e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.05e-05	0.000239	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP19A1—esophageal cancer	4.75e-05	0.000224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	4.72e-05	0.000223	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—esophageal cancer	4.51e-05	0.000213	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.34e-05	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	4.25e-05	0.000201	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.16e-05	0.000197	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	3.85e-05	0.000182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	3.78e-05	0.000179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	3.62e-05	0.000171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—NOS3—esophageal cancer	3.45e-05	0.000163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	3.29e-05	0.000155	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	3.23e-05	0.000152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—esophageal cancer	2.85e-05	0.000135	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.78e-05	0.000131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	2.76e-05	0.00013	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—esophageal cancer	2.62e-05	0.000124	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—NOS3—esophageal cancer	2.49e-05	0.000118	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—esophageal cancer	2.29e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.28e-05	0.000108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—esophageal cancer	2.24e-05	0.000106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	1.94e-05	9.17e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—esophageal cancer	1.89e-05	8.95e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—esophageal cancer	1.88e-05	8.87e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.4e-05	6.62e-05	CbGpPWpGaD
